DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
HGP0904 is an investigational drug.
There have been 7 clinical trials for HGP0904. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2014.
The most common disease conditions in clinical trials are Hypertension, Dyslipidemias, and Hyperlipidemias. The leading clinical trial sponsors are Hanmi Pharmaceutical Company Limited, Seoul National University Bundang Hospital, and [disabled in preview].
There is one US patent protecting this investigational drug and twenty-three international patents.
Recent Clinical Trials for HGP0904
|A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia||Hanmi Pharmaceutical Company Limited||Phase 3|
|A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.||Hanmi Pharmaceutical Company Limited||Phase 1|
|A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.||Hanmi Pharmaceutical Company Limited||Phase 1|
Top disease conditions for HGP0904
Top clinical trial sponsors for HGP0904
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|HGP0904||Get Started Free||Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof||The Regents of the University of California (Oakland, CA)||Get Started Free|
|HGP0904||Get Started Free||Matrix and layer compositions for protection of bioactives||Novus International, Inc. (St. Charles, MO)||Get Started Free|
|HGP0904||Get Started Free||Compositions and methods of use of phorbol esters for the treatment of stroke||Biosuccess Biotech Co. Ltd. (Santa Clara, CA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|HGP0904||European Patent Office||EP2981556||2033-04-02||Get Started Free|
|HGP0904||World Intellectual Property Organization (WIPO)||WO2014165513||2033-04-02||Get Started Free|
|HGP0904||Australia||AU2013290122||2032-07-12||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|